Patents
Patents for C07K 19 - Hybrid peptides (29,428)
01/2002
01/17/2002WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002WO2002004522A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery
01/17/2002WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/17/2002WO2002004499A1 Chemokine receptor modulators, production and use
01/17/2002WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
01/17/2002WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof
01/17/2002WO2001047543A3 Activation and inhibition of the immune system
01/17/2002WO2001046228A3 Nucleic acid vaccination
01/17/2002WO2001034833A3 Regulating endogenous inhibitor at atp synthase
01/17/2002WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
01/17/2002WO2001032696A3 Traf family proteins
01/17/2002WO2001021656A3 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
01/17/2002WO2001007471A3 Cell cycle and proliferation proteins
01/17/2002WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
01/17/2002US20020006903 Genetic engineering
01/17/2002US20020006379 Diagnosis of tissue damage, cancer
01/17/2002CA2658217A1 Expression system
01/17/2002CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer
01/17/2002CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002CA2414387A1 Drug metabolizing enzymes
01/17/2002CA2414272A1 Bifunctional molecules and vectors complexed therewith for targeted gene delivery
01/17/2002CA2413045A1 Expression system
01/17/2002CA2412162A1 Chemokine receptor modulators, production and use
01/17/2002CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
01/16/2002EP1171602A1 Anti-angiogenic intestinal peptides, zdint5
01/16/2002EP1171600A2 Zalpha13: a human secreted protein
01/16/2002EP1171599A1 Adipocyte complement related protein homolog zacrp2
01/16/2002EP1171592A1 A method of altering the properties of a membrane-associated protein by substitution of the transmembrane domain
01/16/2002EP1171098A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
01/16/2002EP0515516B1 Methods for identifying heterofunctional fusion proteins
01/16/2002CN1331701A Modified peptides as therapeutic agents
01/15/2002US6338952 Stress proteins and uses therefor
01/15/2002CA2001719C Phosphorylated fusion proteins and uses related thereto
01/14/2002CA2352036A1 Crystal structure of antibiotics bound to the 30s ribosome and its use
01/10/2002WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME
01/10/2002WO2002002780A2 Human serine-threonine kinase
01/10/2002WO2002002757A2 Adenylyl and guanylyl cyclases
01/10/2002WO2002002751A2 Alteration of cell membrane
01/10/2002WO2002002641A1 Antibodies that immunospecifically bind to blys
01/10/2002WO2002002633A2 Transporters and ion channels
01/10/2002WO2002002629A2 Grf2-binding proteins and applications thereof
01/10/2002WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same
01/10/2002WO2002002624A2 B7-like molecules and uses thereof
01/10/2002WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/10/2002WO2002002603A2 Protein modification and maintenance molecules
01/10/2002WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
01/10/2002WO2002002143A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
01/10/2002WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
01/10/2002WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
01/10/2002WO2001038358A3 Hbv/hcv virus-like particle
01/10/2002WO2001036452A3 Heteroclitic analogs of class i epitodes
01/10/2002WO2001018050A3 T2r taste receptor family
01/10/2002WO2000075347A3 Tet repressor-based transcriptional regulatory proteins
01/10/2002WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same
01/10/2002US20020004587 Antibody for use in the treatment of cancer; antitumor agents
01/10/2002US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer
01/10/2002US20020004202 In vivo screen using chemical inducers of dimerization
01/10/2002CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same
01/10/2002CA2414672A1 Novel human serine-threonine kinase
01/10/2002CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer
01/10/2002CA2413715A1 Grf2-binding proteins and applications thereof
01/10/2002CA2413262A1 B7-like molecules and uses thereof
01/10/2002CA2413237A1 Alteration of cell membrane for new functions
01/10/2002CA2413128A1 Transporters and ion channels
01/10/2002CA2412872A1 Protein modification and maintenance molecules
01/10/2002CA2412845A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
01/10/2002CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
01/10/2002CA2410953A1 Adenylyl and guanylyl cyclases
01/10/2002CA2407910A1 Antibodies that immunospecifically bind to blys
01/09/2002EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility
01/09/2002EP1170300A1 Method for modification of recombinant polypeptides
01/09/2002EP1170016A2 Urease-based vaccine against helicobacter infection
01/09/2002EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
01/09/2002EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection
01/09/2002EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same
01/09/2002EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
01/09/2002EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer
01/09/2002EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/09/2002EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof
01/09/2002EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer
01/09/2002EP1169342A2 Tuberculosis antigens and methods of use therefor
01/09/2002CN1330713A Zinc finger binding domains for GNN
01/09/2002CN1330665A Multiple domain glycoprotein hormones and methods of using
01/08/2002CA2166198C Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins
01/08/2002CA2118113C Oil-body proteins as carriers of high-value peptides in plants
01/08/2002CA2021594C Antibody to human interleukin-6 receptor
01/08/2002CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof
01/03/2002WO2002000991A1 Method for improving transfection efficiency
01/03/2002WO2002000892A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
01/03/2002WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
01/03/2002WO2002000880A1 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters
01/03/2002WO2002000867A1 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen
01/03/2002WO2002000724A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
01/03/2002WO2002000721A2 Cytokine receptor zcytor17
01/03/2002WO2002000710A2 B7-like molecules and uses thereof
01/03/2002WO2002000691A2 Polynucleotides and polypeptides encoded thereby
01/03/2002WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
01/03/2002WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/03/2002WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
01/03/2002WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them